NeuroExplorer-PET: 20x Sharper Brain Imaging for Early Disease Detection
UZ Leuven integrated the United Imaging Healthcare NeuroExplorer-PET scanner into routine clinical operations in June 2026. According to experts, the system produces images up to 20 times sharper than conventional PET scans, potentially allowing for the detection of Alzheimer’s, Parkinson’s, and ALS years before symptoms appear.
The transition from study phases to daily clinical use means the technology is now integrated into workflows involving patient transport and quality assurance. This move shifts the technical requirements from laboratory feasibility to continuous operational stability.
How does the NeuroExplorer-PET improve brain imaging?
The system focuses on spatial resolution rather than simply increasing the volume of data. Professor Koen Van Laere of KU Leuven stated that the NeuroExplorer allows for the first time the capture of biological processes in the brain’s smallest structures, including the brainstem.
This level of detail is compared to a nearsighted person receiving their first pair of glasses. While the environment remains the same, relevant structures become reliably visible, which allows clinicians to verify hypotheses more quickly.
Why does higher resolution matter for neurodegenerative diseases?
Spatial resolution approaching the millimeter range allows clinicians to visualize structures and trajectories that were previously blurred or detected too late. This capability supports the use of biomarkers to identify disease mechanisms earlier.
Clinicians note that this precision could support diagnoses years before the onset of first symptoms for ALS, Parkinson’s, and Alzheimer’s. It also provides benefits for surgical disciplines, such as the more precise removal of micro-tumors or the accurate placement of electrodes for deep brain stimulation.
What other imaging technologies are emerging?
The trend toward data-driven imaging pipelines is evident in other systems. The Flevoziekenhuis in Almere has become the first clinic to use the Philips Rembra-CT scanner, which utilizes AI to optimize images.
While different from PET, this CT technology follows the same strategic path of automating noise reduction and reconstruction. For medical technology providers, competition is shifting from pure hardware power to the integration of these tools into existing clinical workflows.
What is the next step for brain research?
Research is expanding through international collaborations. University Medicine Magdeburg has established the Transatlantic Network of Excellence to study cerebral amyloid angiopathy.
The project is supported by the Leducq Foundation with approximately $9 million (roughly 8 million euros) and includes partners such as Boston University and Harvard Medical School. An official start is scheduled for early 2027.
This network may create a broader ecosystem of validated image pipelines. Such developments could eventually bridge the gap between high-level research and routine patient care.
Frequently Asked Questions
What is the primary advantage of the NeuroExplorer-PET scanner?
According to experts, the scanner provides images that are up to 20 times sharper than those produced by conventional PET procedures.
Which diseases could be diagnosed earlier using this technology?
The higher resolution may support the diagnosis of Alzheimer’s, Parkinson’s, and ALS years before the first symptoms appear.
How does the new system handle data privacy?
The processing of PET and CT data in the EU must follow GDPR rules and site-specific requirements regarding access, purpose, and storage duration.
Do you believe earlier detection of neurodegenerative diseases will fundamentally change how we approach elderly care?